Abstract: A device for performing immunoassay tests includes a readable device for performing immunoassay tests having a platform with at least two sample receiving units. Each sample receiving unit is fluidly connectable to at least two test units, each of which includes a reagent incubation chamber fluidly connected to a separation unit connected to a detection chamber. The platform includes a volume indication unit for detecting the presence of a predetermined volume of the liquid biological sample, and a reading device for performing immunoassay tests. A recognition unit recognizes the presence of the readable device and/or extracts information from a legible identification unit of the readable device. A first optical sensor detects the presence of a binding pair of molecules in the separation unit and/or the presence of free molecules in the detection chamber. A second optical sensor detects the presence of a liquid biological sample in the overflow chamber.

Abstract: A method and device for facilitating fluid communication between a sealed container having an access port and at least one fluid passageway. The device includes a connector provided with a body that defines a fluid passageway between first and second ends of the body. The first end of the body is configured for receiving the fluid source, and the second end is configured for receiving an access port of the container. A locking member is associated with the body and prevents movement of the body relative to the access port when the locking member is in a locked position. The device can be used for the transfer of cytotoxic or other drugs (i.e., fluids) to the container and may remain attached to the access port and used to administer a drug from the container to a patient by means of an administration set with a male luer connector.

Abstract: A method and device for facilitating fluid communication between a sealed container having an access port and at least one fluid passageway. The device includes a connector provided with a body that defines a fluid passageway between first and second ends of the body. The first end of the body is configured for receiving the fluid source, and the second end is configured for receiving an access port of the container. A locking member is associated with the body and prevents movement of the body relative to the access port when the locking member is in a locked position. The device can be used for the transfer of cytotoxic or other drugs (i.e., fluids) to the container and may remain attached to the access port and used to administer a drug from the container to a patient by means of an administration set with a male luer connector.